Page 39 - Delaware Medical Journal - March/April 2021

TREATMENT
of BPSD can be achieved by increasing staff training on BPSD and implementing behavioral health consultation within facilities. More research needs to be
done to assess the impact of BPSD and

LTCFs, particularly in facilities that do not accept people with dementia on new admission, but must cope with the later development of dementia and BPSD. Finally, the development of training and dissemination of guidelines incorporating evidence–based interventions and their implementation in managing BPSD could improve care, decrease stress on residents and caregivers, and reduce some avoidable health care costs.
REFERENCES
1. Aigbogun MS, Stellhorn R, Hartry A, Baker RA, Fillit H. Treatment patterns and burden of behavioral disturbances in patients with dementia in the United States: A claims database analysis. BMC Neurol. 2019;19(1). doi:10.1186/s12883-019-1260-3
2. Finkel SI, Costa e Silva J, Cohen G, Miller S, Sartorius N. Behavioral and psychological signs and symptoms of dementia: A consensus statement on current knowledge and implications for research and treatment. In: International Psychogeriatrics. Vol 8. Int Psychogeriatr; 1996:497-500. doi:10.1017/S1041610297003943
3. Lyketsos CG, Steinberg M, Tschanz JAT, Norton MC, Steffens DC, Breitner JCS. Mental and behavioral disturbances in dementia: Findings from the cache county study on memory in aging. Am J Psychiatry. 2000;157(5):708-714. doi:10.1176/appi.ajp.157.5.708
4. Müller-Spahn F. Behavioral disturbances in dementia. Dialogues Clin Neurosci. 2003;5(1):49-59. Accessed October 26, 2020. http://www.ncbi.nlm.nih.gov/pubmed/22034255
5. Steinberg M, Shao H, Zandi P, et al. Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: The Cache county study. Int J Geriatr Psychiatry. 2008;23(2):170-177. doi:10.1002/gps.1858
6. Kales HC, Gitlin LN, Lyketsos CG. Management of neuropsychiatric symptoms of dementia in clinical settings: Recommendations from a multidisciplinary expert panel. J Am Geriatr Soc. 2014;62(4):762-769. doi:10.1111/jgs.12730
7. Tractenberg RE, Weiner MF, Thal LJ. Estimating the prevalence of agitation in community-dwelling persons with Alzheimer’s disease. J Neuropsychiatry Clin Neurosci. 2002;14(1):11-18. doi:10.1176/jnp.14.1.11
8. Lyketsos CG, Carrillo MC, Ryan JM, et al. Neuropsychiatric symptoms in Alzheimer’s disease. Alzheimer’s Dement. 2011;7(5):532-539. doi:10.1016/j.jalz.2011.05.2410
■ CLAUDINE JURKOVITZ, MD, MPH is the Director of Clinical Research in the Value Institute at ChristianaCare and lead of the Biostatistics Epidemiology Research Design (BERD) core of the Delaware ACCEL-Center for Translational Research (CTR). As such, she helps physicians, residents, and young investigators at ChristianaCare and other ACCEL-CTR Institutions to develop their research projects and analytical plan.
■ JAMES M. ELLISON, MD, MPH holds the Swank Foundation Endowed Chair in Memory Care and Geriatrics at ChristianaCare, directs the Swank Center for Memory Care and Geriatric Consultation, and focuses on improving the
care of Delaware’s older adults living with neurocognitive disorders and their caregivers.
CONTRIBUTORS
■ STEVEN J. BANKO is a senior at Georgetown University studying health care policy, planning on pursuing a career in medicine following graduation.
■ CECELIA HARRISON, MPH is a masters-level epidemiologist with experience in research coordination, study management, and statistical analysis. As a Research Associate in the Value Institute at ChristianaCare, Harrison focuses
on using epidemiologic methodology to inform health services and public health research, health care policies, and related interventions.
■ JENNIFER RITTEREISER, MPH is the Director
of the Swank Center’s Memory Ambassadors Program, a community-based educational outreach program that provides education on cognitive aging, brain-healthy lifestyle interventions, and free and confidential memory screenings.
9. Geda YE, Schneider LS, Gitlin LN, et al. Neuropsychiatric symptoms
in Alzheimer’s disease: Past progress and anticipation of the future. Alzheimer’s Dement. 2013;9(5):602-608. doi:10.1016/j.jalz.2012.12.001
10. Ismail Z, Smith EE, Geda Y, et al. Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment. Alzheimer’s Dement. 2016;12(2):195-202. doi:10.1016/j.jalz.2015.05.017
11. Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, Dekosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: Results from the cardiovascular health study. J Am Med Assoc. 2002;288(12):1475-1483. doi:10.1001/jama.288.12.1475
12. Kales HC, Gitlin LN, Lyketsos CG. Assessment and management of behavioral and psychological symptoms of dementia. BMJ. 2015;350. doi:10.1136/bmj.h369
13. Herrmann N, Lanctôt KL, Sambrook R, et al. The contribution of neuropsychiatric symptoms to the cost of dementia care. Int J Geriatr Psychiatry. 2006;21(10):972-976. doi:10.1002/gps.1594
14. Schnaider Beeri, M., Werner, P., Davidson, M., & Noy S. The cost
of behavioral and psychological symptoms of dementia (BPSD) in community dwelling Alzheimer’s disease patients. Int J Geriatr Psychiatry. 2002;17(5):403-408.
15. Jeffrey L. Cummings. The Neuropsychiatric Inventory Questionnaire: Background and Administration.; 1994. https://download.lww. com/wolterskluwer_vitalstream_com/PermaLink/CONT/A/ CONT_21_3_2015_02_26_KAUFER_2015-10_SDC2.pdf
16. Riley RJ, Burgener S, Buckwalter KC. Anxiety and stigma in dementia: A threat to aging in place. Nurs Clin North Am. 2014;49(2):213-231. doi:10.1016/j.cnur.2014.02.008
Del Med J | March/April 2021 | Vol. 93 | No. 2
87